Article Data

  • Views 2137
  • Dowloads 119

Original Research

Open Access

Ultrasound and X-ray performance of breast carcinosarcoma

  • Zhi-Ying Jia1,*,
  • Xiu-Qing Ai2
  • Yin-Hua Zhang3
  • Li Li4
  • Fu-Cheng Ma1

1Department of Ultrasound, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China

2Department of Breast Radiotherapy, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China

3Department of Pathology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China

4Department of Radiology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China

DOI: 10.12892/ejgo4456.2018 Vol.39,Issue 6,December 2018 pp.943-947

Published: 15 December 2018

*Corresponding Author(s): Zhi-Ying Jia E-mail: jiazy364@sina.com

PDF (264.19 kB) View Full-text

Abstract

Objective: In this study, the authors investigated the ultrasonic and X-ray performance of this disease, and evaluated the value of routine imaging methods in the diagnosis of breast carcinosarcoma. Materials and Methods: Nine female patients with breast carcinosarcoma were enrolled. Ultrasound and X-ray are commonly used imaging methods for the diagnosis of breast diseases. Hence, the ultrasonic appearance and X-ray features of these nine cases of breast carcinosarcoma were retrospective analyzed, and the imaging features of carcinosarcoma were summarized based on pathological changes. Results: The pathological histology and immunohistochemical findings of these nine cases of breast carcinosarcoma revealed that five cases were epithelium-derived malignant tumors and four cases were mesenchymal metaplasia. Axillary lymph node metastasis was not found in any of these cases. Before surgery, ultrasound diagnoses included six cases of breast cancer, one case of phyllodes tumor, and two cases of fibroadenoma; while breast X-ray diagnoses included one case of fibroadenoma, two cases of suspected malignant tumors, four cases of breast cancer, and two cases of phyllodes tumor. Furthermore, ultrasound imaging revealed tumors with irregular shapes in six cases, internal liquefaction necrosis in four cases, internal calcification in two cases, and posterior echo enhancement in seven cases; while breast X-ray revealed lobulated changes on the margins in six cases, irregular tumors with horn-shaped protrusions in three cases, and internal calcification in six cases. Conclusion: It is difficult to diagnose breast carcinosarcoma by imaging methods, and puncture biopsy is an important method for preoperative diagnosis.

Keywords

Breast; Carcinosarcoma; Ultrasonography; Mammography.

Cite and Share

Zhi-ying Jia, Xiu-qing Ai, Yin-hua Zhang, Li Li, Fu-cheng Ma. Ultrasound and X-ray performance of breast carcinosarcoma. European Journal of Gynaecological Oncology. 2018; 39(6): 943-947. doi: 10.12892/ejgo4456.2018

References

[1] Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., et al.: “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012”. Int. J. Cancer, 2015, 136, E359.

[2] Kumar S.S., Prateek A., Vishu M.: “Breast cancer diagnosis using digital image segmentation techniques”. Indian J. Science Tech., 2016, 9, 1.

[3] Panesar S., Neethirajan S.: “Microfluidics: Rapid Diagnosis for Breast Cancer”. Nano-Micro Letters, 2016, 8, 1.

[4] McCullough L.E., Chen J., Cho Y.H., Khankari N.K., Bradshaw P.T., White A.J., et al.: “DNA methylation modifies the association between obesity and survival after breast cancer diagnosis”. Breast Cancer Res. Treat., 2016, 156, 183.

[5] Stein R.G., Wollschläger D., Kreienberg R., Janni W., Wischnewsky M., Diessner J., et al.: “The impact of breast cancer biologicalsubtyping on tumor size assessment by ultrasound and mammography - aretrospective multicenter cohort study of 6543 primary breast cancer patients”. BMC Cancer, 2016, 16, 459.

[6] McDonald E.S., Clark A.S., Tchou J., Zhang P., Freedman G.M.: “Clinical Diagnosis and Management of Breast Cancer”. J. Nucl. Med., 2016, 57, 9S.

[7] Berg W.A., Zhang Z., Lehrer D., Jong R.A., Pisano E.D., Barr R.G., et al.: “Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk”. JAMA, 2012, 307, 1394.

[8] Nieciecki M., Dobruch-Sobczak K., Wareluk P., Gumińska A., Białek E, Cacko M., Królicki L.: “The role of ultrasound and lymphoscintigraphy in the assessment of axillary lymph nodes in patients with breast cancer”. J. Ultrason., 2016, 16, 5.

[9] Dummin L.J., Cox M., Plant L.: “Prediction of breast tumor size by mammography and sonography–A breast screening experience”. Breast, 2007, 16, 38.

[10] Bandos A.I.: “Breast cancer detection rate using ultrasound is shown to be comparable to mammography”. J. Natl. Cancer Inst., 2016, 108, 408.

[11] Evans D.G., Kesavan N., Lim Y., Gadde S., Hurley E., Massat N.J., et al.: “Erratum to: MRI breast screening in high-risk women: cancer detection and survival analysis”. Breast Cancer Res. Treat., 2014, 145, 663.

[12] Al Sayed A.D., El Weshi A.N., Tulbah A.M., Rahal M.M., Ezzat A.A.: “Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factors”. Acta Oncol., 2006, 45, 188.

[13] Esses K.M., Hagmaier R.M., Blanchard S.A., Lazarchick J.J., Riker A.I.: “Carcinosarcoma of the breast:two case reports and review of literature”. Cases J., 2009, 2, 15.

[14] Zhang Y., Cao M.Z.: “Clinical characteristic of breast carcinosarcoma in pathology and biology”. Chinese Archives of General Surgery (electronic version), 2009, 3, 499.

[15] Yang Y.X., Zhang L.P., Guo G.C.: “Analysis of clinicopathological features and prognosis of 94 patients with breast carcinosarcoma”. Tumor, 2013, 33, 63.

[16] Wang Y.X., Lu S., Wang T., Liu H.: “Breast Carcinosarcoma:A Clinicopathological Analysis of 23 Cases”. Chinese J. Clin. Oncol., 2012, 39, 656.

[17] Gogas J., Kouskos E., Markopoulos C., Mantas D., Antonopoulou Z., Kontzoglou K., et al.: “Carcinosarcoma of the breast:report of two cases”. Eur. J. Gynaecol. Oncol., 2003, 24, 93.

[18] Beatty J.D., Atwood M., Tickman R., Reiner M.: “Metaplastic breast cancer: clinical significance”. Am. J. Surg., 2006, 191, 657.

[19] Lim K.H., Oh D.Y., Chie E.K., Han W., Im S.A., Kim T.Y., et al.: “Metaplastic breast carcinoma:clinicalpathologic features and prognostic value of triple negativity”. Jpn. J. Clin. Oncol., 2010, 40, 112.

[20] Kitada M., Yasuda S., Takahashi N., Okazaki S., Ishibashi K., Hayashi S.: “Clinicopathological study of epithelial metaplastic breast cancer”. J. Cancer Ther., 2016, 7, 1039.

[21] Yang W.T., Hennessy B., Broglio K., Mills C., Sneige N., Davis W.G., et al.: “Imaging differences in metaplastic and invasive ductal carcinomas of the breast”. AJR Am. J. Roentgenol., 2007, 189, 1288.

[22] Sun K., Chen K.M., Chai W.M., He N.Y., Yan F.H.: “Multimodality imaging of metaplastic breast carcinoma”. J. Pract. Radiol., 2013, 29, 1221.

[23] Chen X.S., Zhang X.J., Lin L.W., Xue E.S., Yu L.Y., He Y.M.: “Application value of color Doppler ultrasound in metaplastic breast carcinoma. Ultrasonography, 2016, 25, 223.

[24] Shi X.X., Liu X.H., Fang Y.Y.: “ A case: breast carcinosarcoma”. Radiol. Prtact., 2013, 28, 783.

[25] Yakan S., Sarı E., Erkan N., Yıldırım M., Vardar E., Coskun A., et al.: “Breast Carcinosarcomas”. Meme Sagligi Dergisi, 2014, 10, 161.

Submission Turnaround Time

Top